- T J Lynch
Baillieres Best Pract Res Clin Haematol 2000 Dec;13(4):669-88
Division of Hematology, U.S. Food and Drug Administration, Rockville, MD, USA.
Proteins derived from human plasma have become critically important therapeutic products since their introduction in the 1940s. In the last 20 years, the tools of molecular biology have provided alternatives to the administration of the natural products. Recombinant analogues of Factor VIII and Factor IX are commercially available, and recombinant forms of other plasma proteins are under development. Read More